David Bonderman

David Bonderman General Information

Description

Dr. David Bonderman is a Founding Partner and serves as Non-Executive Chairman, Member of the Executive Committee, and Board Member at TPG. He served as Board Member at XO. He serves as Board Member at Allogene Therapeutics. He is a Co-Owner of Boston Celtics. He is a Co-Owner of Seattle Kraken. He served as Board Member at STX Entertainment. Dr. Bonderman JD is a high-net-worth individual. He also served as the Chairman of TPG Pace Holdings. He also serves as Board Member at STX Entertainment. He served as Advisor at Russian Direct Investment Fund. He co-founded TPG Newbridge in 1992. Today, portfolio companies controlled by TPG have combined revenues of over US $130 billion, operate in more than 100 countries, and employ approximately 550,000 people. Prior to co-founding TPG, Dr. David Bonderman serves as Chairman at Ryanair. Mr. Bonderman was the Chief Operating Officer of the Robert M. Bass Group, Inc. (RMBG), now doing business as Keystone Group, L.P. in Fort Worth, Texas. Mr. Bonderman graduated Magna Cum Laude from Harvard Law School in 1966 and was a member of the Harvard Law Review and a Sheldon Fellow. He was also a Board Member of Univision Communications. He is also the Co-Founder of Wildcat Capital Management. He also served as a Director at China International Capital Corporation.